Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
about
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseGlial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expressionGenetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory responseNanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors.Plant derived edible nanoparticles as a new therapeutic approach against diseases.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Targeted delivery systems for biological therapies of inflammatory diseases.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerOral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.
P2860
Q28073219-47CD4F70-84DB-40E7-A45A-0D72F9B8C4F9Q28354027-11279332-1E7C-4500-AC02-229E43A51039Q33881932-BF36771E-8196-40B2-BE4D-022E4C4EE8BDQ34953629-67BBF232-9F02-4940-A301-927F0BB58FC0Q35619546-363C01D4-D83B-4864-9B48-011247CB5716Q36757136-64F80FEF-4953-4B16-86A7-84FFDE2D213BQ37012929-B4AAD8B9-C4F7-4D80-832D-2B90536AAB9EQ37469872-ADAC2876-EFC8-4269-81C0-BA410E12DFDCQ38264691-ED46B47E-5B13-4A85-BB4C-97A8045EF8AAQ38659150-C3FDF6DF-2D1D-42DF-87A7-0468D7FC055AQ39038930-F422D1DE-62B3-48F2-B3AB-999701CAB0ADQ39170844-114B128B-4A98-4EE0-A5F2-80D92187C1BDQ42176588-FA9092E4-EE41-44AD-855D-A7E180E92104Q47840447-F1804E8D-1A95-4F80-818B-82739F5F31BDQ47980720-8F7BF9A3-3206-4C43-99BC-DF2A97705584Q49612238-7D74D80C-AFCC-4BF8-B4F9-CB527691A06A
P2860
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@en
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@nl
type
label
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@en
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@nl
prefLabel
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@en
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles
@en
P2093
Didier Merlin
Hamed Laroui
Poonam Rakhya
P2860
P356
10.1038/MT.2013.214
P577
2013-09-12T00:00:00Z